A Third Phase, Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoiditis Among Adults

Trial Profile

A Third Phase, Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoiditis Among Adults

Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 Jan 2016

At a glance

  • Drugs Ciprofloxacin (Primary) ; Secnidazole (Primary) ; Amoxicillin/clavulanic acid
  • Indications Bacterial infections; Diverticulitis; Intra-abdominal infections
  • Focus Therapeutic Use
  • Acronyms DIVA
  • Most Recent Events

    • 17 Dec 2012 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record NCT01733966.
    • 17 Dec 2012 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record NCT01733966.
    • 21 Nov 2012 New source identified and integrated: ClinicalTrials.gov record NCT01733966.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top